Amantadine-induced peripheral neuropathy

Neurology

Volumn 53, Issue 8, 1999, Pages 1862-1865

  Shulman, Lisa M ^a   Minagar, Alireza ^a   Sharma, Khema ^a   Weiner, William J ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Amantadine; PD; Peripheral neuropathy

Indexed keywords

AMANTADINE;

ADULT; ARTICLE; CASE REPORT; DRUG EFFECT; FEMALE; HUMAN; MUSCLE WEAKNESS; PARESTHESIA; PARKINSON DISEASE; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; SENSORIMOTOR FUNCTION; SKIN ULCER;

EID: 0033544369     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.53.8.1862     Document Type: Article

References (6)

1. Schwab RS, England AC Jr, Poskanzer DC, et al. Amantadine in the treatment of Parkinson's disease. JAMA 1969;208:1168-1170.
2. Shealy CN, Weeth JB, Mercier D. Livedo reticularis in patients with parkinsonism receiving amantadine. JAMA 1970;212: 1522-1525.
3. Silver DE, Sahs AL. Livedo reticularis in Parkinson's disease patients treated with amantadine hydrochloride. Neurology 1972;22:665-669.
4. Pearce LA, Waterburry LD, Green H. Amantadine hydrochloride: alteration in peripheral circulation. Neurology 1974;24: 46-48.
5. Vollum DI, Parkes JD, Doyle D. Livedo reticularis during amantadine treatment. Br Med J 1971;2:627-628.
6. Grelak RP, Clark R, Stump JM, Vernier VG. Amantadine-dopamine interaction: possible mode of action in parkinsonism. Science 1970;169:203-204.